Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




CVAT, SBUX, PWRM, CVS, PSFT, SWKS, AQNM, IBM, CSRH, DrStockPick.com Stock Report!

Dr. Stock Pick (November 6th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Friday November 6, 2009

DrStockPick.com Stock Report!

CVAT, SBUX, PWRM, CVS, PSFT, SWKS, AQNM, IBM, CSRH

**************************************************************

PSFT, Powersafe Technology Corp., PSFT.PK

PSFT subsidiary Amplification Technologies Inc. (www.amplificationtechnologies.com) (ATI), is offering higher performance thermoelectrically cooled discrete amplification single photon counting solid state photodetectors. These photodetectors are mounted on a two stage thermoelectric cooler inside a hermetically sealed TO8 package and can be operated down to a temperature of -30oC.

The devices are available in both Si and InGaAs/InP technologies. As compared to TO5 devices, these TO8 packaged detectors have 10-30X lower dark current depending on operating temperature. The Si devices offer flat and

...
Tags for this Post:
(718) 951-8021, (818) 718-0905, (951) 657-8832, +1 866 824 8854, advertisement services, advertising services, ALS, Amplification Technologies Inc., analog, Aquentium Inc.;, Beijing, Best Coffee, beverage, Breast Cancer, broker, California, cancer, Cavitation Technologies Inc., Chair and Keynote Speaker, chemical industries, Chemicals, chief scientific officer, China, Congress, Consorteum Holdings Inc.;, cost savings technology, cost-savings;, Crown Equity Holdings Inc.;, crude oil refining;, CSRH, Cvs, CVS Caremark Corp., diagnostic tests, Dr Stock Pick, e-coli, end-product, energy, equity trader, Europe, Fda, food, food additive, food product, food products, Food Safety, green technologies;, high-energy physics, Houston, Ibm, improved food safety standards, information ;, Information Technology, information technology products, InGaAs/InP technologies, International Business Machines Corp., International Congress, Investing Lessons, Ira Goldknopf, Jack Mayer, Krishna Linga, leader in the development, light level imaging, Mark Taggatz;, medical imaging, mining, mixed signal semiconductors enabling wireless connectivity, neurodegenerative disease;, non-chemical process;, non-chemical processing, non-chemical sanitation equipment, North America, ozone equipment;, Palm Springs, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, PowerSafe Technology Corp., president, President & COO, professional investment analyst and consultant, PSFT, Quent Rickerby;, related healthcare services, sanitation equipment, seafood processor, seafood processors, Seattle, semiconductor, Semiconductors, Skyworks Solutions Inc., spectroscopy, Starbucks Corp.;, stock featured on our site;, Stock Pick, Stocks to Watch, Texas, United States, USD, USDA, vegetable oil refining, Waste To Energy, www.amplificationtechnologies.com, www.aquentium.com, www.consorteum.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com

Express Scripts Reports In-Line – Analyst Blog

Zacks Market Commentaries (October 29th, 2009) Writes:
Express Scripts Inc. (ESRX) announced third-quarter earnings of 81 cents per share, in-line with the Zacks Consensus Estimate as well as last year's profit. Revenues, however, increased 3% to $5.6 billion with product revenues increasing 3.1% to $5.5 billion.   The company reports revenues from two segments: Pharmacy Business Management (PBM) and Emerging Markets (EM). PBM product revenue consists of revenues from the sale of prescription drugs by retail pharmacies in the company’s retail pharmacy networks and revenues from the dispensing of prescription drugs from the company’s home delivery and specialty pharmacies. EM product revenues consist of distribution of certain fertility drugs and revenues from drug distribution services.   PBM revenues increased 3.5% to $5.3 billion with network pharmacy revenues increasing by 3.4% mainly due to higher claims volume that were partially offset by price decreases. New clients contributed to the increase in claims volume. Meanwhile, generic fill rate increased to ...

Office Depot Introduces Flu Kit – Analyst Blog

Zacks Market Commentaries (October 13th, 2009) Writes:
Office Depot Inc. (ODP), the global supplier of a range of office products and services, recently teamed up with Acme United to offer ‘Fight the Flu Kit’. With the spread of swine flu (H1N1 virus), more and more businesses are taking measures to prevent their employees from being infected by the deadly virus.   The ‘Fight the Flu Kit’ designed by Acme United's PhysiciansCare includes a facemask, gloves, hand sanitizer, cleaning wipes, and facial tissues, and is currently available for $7.99 at Office Depot retail locations.   There are companies also offering seasonal flu vaccines. Kroger Co. (KR) had earlier made seasonal flu vaccines available at its 1,900 stores, effective September 2009. Target Corp. (TGT) is also offering flu vaccinations readily available at over 1,500 Target Pharmacy locations nationwide effective October. These vaccines do not safeguard against the deadly H1N1 flu, but are essential to protect ...

It’s a constant struggle to remain at the top!

stock-pr (August 20th, 2009) Writes:

CVS Caremark Corp. (CVS) Current share price $34.97

August 20, 2009 CVS by size and dollar volume is the leader in the drugstore marketplace, operating over 6,900 CVS/pharmacy stores in 44 states, the District of Columbia , and Puerto Rico . At year-end (Dec. 2008), they operated 6,923 drugstores, 560 MinuteClinic locations, 58 retail specialty pharmacy stores, 19 specialty mail order pharmacies, six mail service pharmacies, and CVS.com; and Caremark.com websites. CVS employs approximately 215,000 colleagues.

The top two major players in drugstore operations, CVS and Walgreens are on an expansion drive to either gain first place or locked in a struggle to retain the lead, so far CVS has held that position followed not to far behind by Walgreens.

Much of each company’s competitive edge comes from acquisitions, with the grand prize going to CVS for its insight in acquiring the well known Long Drug Store logo in August 2008. This acquisition

...

Zacks Analyst Blog Highlights: Medco Health Solutions, CVS Caremark Corp, Express Scripts, WellPoint Inc. and Whole Foods Market – Press Releases

Zacks Market Commentaries (August 6th, 2009) Writes:

For Immediate Release

Chicago, IL – August 6, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Medco Health Solutions (MHS), CVS Caremark Corp (CVS), Express Scripts (ESRX), WellPoint Inc. (WLP) and Whole Foods Market (WFMI).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Wednesday’s Analyst Blog:

Medco Earnings Beat Estimates

Revenues from Medco Health Solutions’ (MHS) specialty pharmacy segment, Accredo Health Group, increased 20.3% to $2.38 billion primarily due to significant addition of new clients and organic growth of the segment.

Based on the robust performance of all the

...

CVS Caremark Enters Oversold Territory – Zacks Tale of the Tape

Zacks Market Commentaries (May 20th, 2009) Writes:

CVS Caremark Corp.'s (CVS) share price has moved into oversold territory with a stochastic value of 5.75. Analysts have been increasing their full-year earnings estimates on the Zacks #2 Rank ("Buy") company, with the consensus up 2 cents over the past 30 days to $2.59 per share.

"CVS" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

Top Janus Funds – Mutual Fund Education

Zacks Market Commentaries (April 29th, 2009) Writes:

Janus Flexible Bond (JAFIX) generates total return from a combination of current income and capital appreciation, but income is usually the dominant portion. The fund provides investors with a mix of bonds in a single portfolio.

The fund primarily invests in bonds including government bonds, corporate bonds, convertible bonds, mortgage-backed securities, and zero-coupon bonds. It invests at least 65% of its assets in investment grade debt securities and will maintain an average-weighted effective maturity of five to ten years.

Gibson Smith has been the lead manager at the fund since May 2007. The fund distributes dividends annually.

Janus Growth & Income (JAGIX) seeks long-term capital growth. While the fund may also emphasize some degree of income, it is not designed for investors who desire a certain level of income.

The fund pursues its investment objective by normally emphasizing investments in common stocks. It invests

...

Express Scripts buys WellPoint Unit – Zacks Tale of the Tape

Zacks Market Commentaries (April 13th, 2009) Writes:

Express Scripts Inc. (ESRX) agreed to buy WellPoint Inc.'s (WLP) pharmacy-benefit management unit for $4.7 billion on Monday to get an edge over larger rivals by negotiating lower prices on prescription medicines.

Express Scripts is the third-largest manager of U.S. drug benefits after MedcoHealth Solutions Inc. (MHS) and CVS Caremark Corp. (CVS). The St. Louis-based company will pay for the NextRX unit with cash and up to $1.4 billion in stock to gain 25 million members. The deal may also add "slightly" to earnings this year, Express Scripts said.

Health insurers have come under severe pressure as rising unemployment makes controlling health-care costs crucial and the Obama administration discusses proposals to slash payments of private Medicare insurers. Under the circumstances, WellPoint put its pharmacy benefits management unit up for sale to unlock shareholder value from the non-core business.

The

...

CVS Caremark Feels Wal-Mart Heat – Analyst Blog

Zacks Market Commentaries (September 8th, 2008) Writes:

CVS Caremark Corp. (CVS) is one of the leaders in the domestic drug store industry and the pharmacy services industry. The management embarked on an aggressive expansion strategy, including the merger of equals with Caremark.

There is substantial operational risk concerning the integration of the five significant acquisitions that were closed during the last two years. Also, generic drug introductions and Wal-Mart's (WMT) entry into the generic drug industry are negatively impacting the profitability of the drug store industry, including CVS Caremark. Therefore, the stock is rated a Hold.

Due to the company's periodic earnings disappointments and aggressive acquisition strategy, the stock is best valued on a price-to-sales basis. The stock traded in the range of 0.37 to 0.80 times sales over the last five years prior to the merger with Caremark and Osco & Sav-On drugstores. The target is $38.50, which is based on a valuation of a

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.